The Company has formed a Scientific Advisory Board comprised of some of the key thought leaders in regenerative medicine, vascular biology, and cosmetic medicine.

Stephen Badylak, DVM, MD, PhD
Research Professor, Department of Surgery
Director of Tissue Engineering, McGowan Institute for Regenerative Medicine
Deputy Director of McGowan Institute for Regenerative Medicine
University of Pittsburgh

Michael Conte, MD
Professor and Chief of Vascular & Endovascular Surgery, UCSF Medical Center
Co-Director, UCSF Heart and Vascular Center
Medical Director, Vascular Noninvasive Laboratory
University of California San Francisco

Moses Goddard, MD
Associate Professor (Research), Surgery
Brown University
Director, Cytotherapeutics

Jeffrey Lawson, MD, PhD
Associate Professor of Surgery and Pathology
Director of Vascular Research Laboratory
Director of Clinical Trials in Vascular Surgery
Duke University

Gail Naughton, PhD
Dean of College of Business Administration
San Diego State University
CEO and Chairman of the Board, Histogen
President, ATS

Jordan Pober, MD, PhD
Professor and Vice Chair of Immunobiology for Human and Translational Immunology
Professor of Dermatology and Pathology
Director, Human and Translational Immunology Program
Vice-Chair, Dept. of Immunobiology for the Section of Human and Translational Immunology
Yale University

Gus Vlahakes, MD
Head of Cardiothoracic Vascular Surgery, Surgical Critical Care
Massachusetts General Hospital